Reduction in Visceral Fat Imaging studies show that semaglutide's weight-loss effect includes a reduction in visceral adipose tissue
The latest evidence supporting the notion that NAFLD is the main factor for incident CKD comes from a recent meta-analysis of 13 studies with a total of 1,222,032 individuals (28.1% with NAFLD)
Although this has been found to be the case, it was also found that other preprocedural GI effects were observed with a higher incidence in GLP-1 RA users such as reduced gastric acidity, nausea, vomiting, dyspepsia, and abdominal distension (OR 15.1
Ozempic face is the nickname for the loss of facial volume and mild sagging that can follow fast weight loss on any GLP-1, not just Ozempic
Pathophysiology 32 (1), 1
During the first two weeks after stopping, most patients notice that hunger gradually returns as medication concentrations drop